Mol Cancer Res. 2010 Oct;8(10):1425-36. Epub 2010 Sep 8.

Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.

Reuter S, Prasad S, Phromnoi K, Kannappan R, Yadav VR, Aggarwal BB.
Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Source

---

Fig. 2A, 6A - "embelin day 1" in Fig.2A and "+ NBP (Medium)" in Fig. 6A are the same image 

Source

---

Fig. 2A - embelin day 3 and embelin days 4 are the same image, rotated 180 degrees.

Source

---

Fig. 5E - cleaved caspase blot, square seams around lane 4, pasted in?

Source

---